A randomized blinded study of the left ventricular myocardial performance index comparing epinephrine to levosimendan following cardiopulmonary bypass

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Filho, Marcello Fonseca Salgado ^a   Barral, Marselha ^b   Barrucand, Louis ^a   Cavalcanti, Ismar Lima ^c   Vercosa, Nubia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Juiz de Fora School of Medical and Health Sciences SUPREMA   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; LEVOSIMENDAN; PROTAMINE; TROPONIN I; CARDIOTONIC AGENT; EPINEPHRINE; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEMALE; HEART FUNCTION; HEART INDEX; HEART RATE; HUMAN; INCIDENCE; INFUSION PUMP; LEFT VENTRICULAR MYOCARDIAL PERFORMANCE INDEX; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; BLOOD; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HEMODYNAMICS; MIDDLE AGED; PROCEDURES;

AGED; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; EPINEPHRINE; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PYRIDAZINES; STROKE VOLUME; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 84956500318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143315     Document Type: Article

References (48)

1. Bajraktari G, Duncan A, Pepper J, Henein M. Prolonged total isovolumic time predicts cardiac events following coronary artery bypass surgery. Eur J Echocardiogr. 2008; 9:779-783. doi: 10.1093/ejechocard/jen146 PMID: 18490287
2. Gandham R, Syamasundar A, Ravulapalli H, Karthekeayan Rb, Vakamudi M, Kodalli R, et al. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair/replacement for severe mitral stenosis. Ann Card Anaesth. 2013; 16:11-15. PMID: 23287080
3. Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg. 2009; 87:448-454. doi: 10.1016/j.athoracsur.2008. 10.029 PMID: 19161758
4. Savaris N. Immunoinflammatory response to cardiopulmonary bypass: An update. Rev Bras Anestesiol. 1998; 48:126-136.
5. Siirilä-Waris K, Suojaranta-Ylinen R, Harjola V-P. Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth. 2005; 19:345-349. doi: 10.1053/j.jvca.2005.03.012 PMID: 16130062
6. Royster RL, Butterworth JF, Prough DS, Johnston WE, Thomas JL, Hogan PE, et al. Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg. 1991; 72:729-736. 0003-2999/9 PMID: 1827965
7. Parissis JT, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A. Inotropes in cardiac patients: Update 2011. Curr Opin Crit Care. 2010; 16:432-441. doi: 10.1097/MCC.0b013e32833e10fb PMID: 20711077
8. Tritapepe L, Santis VD, Vitale D, Santulli M, Morelli A, Nofroni I, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-a pilot study. Br. J. Anaesth. 2006; 96:694-700. doi: 10. 1093/bja/ael082 PMID: 16595616
9. Hasenfuss G, Teerlink JR. Cardiac inotropes: Current agents and future directions. Eur Heart J. 2011; 32:1838-1845. doi: 10.1093/eurheartj/ehr026 PMID: 21388993
10. Kodalli RK, Sundar AS, Vakamudi M, Ravulapali H, Nandipati S, Chandrasekaran N, et al. Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: A randomized controlled study. Ann Card Annaesth. 2013; 16:94-99. doi: 10.4103/0971-9784. 109737
11. Rambihar S, Dokainish H. Right ventricular involvement in patients with coronary artery disease. Curr Opin Cardiol. 2010; 25:456-463. PMID: 20592585
12. Duncan AM, Francis DP, Henein MY, Gibson DG. Importance of left ventricular activation in determining myocardial performance (tei) index: Comparison with total isovolumic time. Int J Cardiol. 2003; 95:211-217. doi: 10.1016/j.ijcard.2003.07.007
13. Salgado AA, Filho FMA, Castier M, Bedirien R. Myocardial performance index: The end of ejection fraction? Rev Br Ecocard. 2004; 17:69-74.
14. Lakoumentas JA, Kotseroglou FK, Kotseroglou VK, Aggeli KI, Harbis PK. The tei index of myocardial performance: Applications in cardiology. Hellenic J Cardiol 2005; 46:52-58 PMID: 15807396
15. Karatziz EN, Giannakopoulou AT, Papadakis JE, Karazachos AV, Nearchou NS. Myocardial performance index (tei index): Evaluating its application to myocardial infarction. Hellenic J Cardiol. 2009; 50:60-65. PMID: 19196622
16. Maleki M, Marzban PM, Haghighi SZO, Noohi F. Effects of coronary bypass surgery on myocardial performance index (mpi or tei index). Iran Heart J. 2005; 6:26-30.
17. Javidi D, Saffarian N. Prognostic value of left ventricular myocardial performance index in patients undergoing coronary artery bypass graft surgery. Arch Iranian Med. 2008; 11:497-501. PMID: 18759516
18. Parthenakis FI, Kanakaraki MK, Kanoupakis EM, Skalidis EI, Diakakis GF, Filippou OK, et al. Value of doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure: Effects of dobutamine. Chest. 2002; 121:1935-1941. PMID: 12065360
19. Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L, et al. Reducing mortality in cardiac surgery with levosimendan: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010; 24:51-57. PMID: 19700350 doi: 10.1053/j.jvca.2009.05.031
20. Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: A meta-analysis. J Cardiothorac Vasc Anesth. 2013; 27:1224-1232. PMID: 24050857 doi: 10.1053/j.jvca.2013.03.027
21. Shanewise JS, Cheung AT, Aronson S, Stewart WJ, Weiss RL, Mark JB, et al. ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: Recommendations of the American Society of Echocardiography council for intraoperative echocardiography and the Society of Cardiovascular Anesthesiologists task force for certification in perioperative transesophageal echocardiography. Anesth Analg. 1999; 12:884-900. 0003-2999/99
22. Thys D, Abel M, Brooker R, Cahalan M, Connis R, Duke P, et al. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists task force on transesophageal echocardiography. Anesthesiology. 2010; 112:1084-1096. PMID: 20418689 doi: 10.1097/ALN.0b013e3181c51e90
23. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Brindis RG, Patel MR, et al. ACCF/ASE/ACEP/ASNC/SCAI/ACCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. A report of the American College of Cardiology Foundation quality strategic directions committee appropriateness criteria working group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Coll Cardiol. 2007; 50:187-204. PMID: 17616306
24. Maslow AD, Regan MM, Schwartz C, Bert A, Singh A. Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosis. Anesth Analg. 2004; 98:891-902. doi: 10. 1213/01.ANE.0000107940.23783.33 PMID: 15041568
25. Skubas N, Perrino A. Assessment of perioperative hemodynamics. In: Savage R, Aronson S, Shernan S, eds. Comprehensive textbook of perioperative transesophageal echocardiography. Philadelphia: Lippincott Williams & Wilkins; 2011:406-425.
26. Hert SGD, Lorsomradee S, Cromheecke S, Linden PJVd. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg. 2007; 104:766-773. doi: 10.1213/01. ane.0000256863.92050.d3 PMID: 17377079
27. Steen PA, Tinker JH, Pluth JR, Barnhirst DA, Tarhan S. Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man. Circulation. 1978; 57:378-384. doi: 10.1161/01.CIR.57.2.378 PMID: 618630
28. Stratton JR, Pfeifer MA, Ritchie JL, Halter JB. Hemodynamic effects of epinephrine: Concentrationeffect study in humans. J Appl Physiol. 1985; 58:1199-1106. PMID: 3988675
29. Papp Z, Édes I, Fruhwald S, Hert SGD, Salmenperä M, Leppikangas H, et al. Levosimendan: Molecular mechanisms and clinical implications. Consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012; 159:82-87. doi: 10.1016/j.ijcard.2011.07.022 PMID: 21784540
30. Raja SG, Rayen BS. Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg. 2006; 81:1536-1546. doi: 10.1016/j.athoracsur.2005.08.073 PMID: 16564321
31. Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg. 2009; 87:448-454. doi: 10.1016/j.athoracsur.2008. 10.029 PMID: 19161758
32. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. Circulation. 2011; 123: E426-e579. doi: 10.1161/CIR.0b013e318212bb8b PMID: 21444888
33. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: The survive randomized trial. JAMA. 2007; 297:883-891. PMID: 17473298
34. Carluccio E, Biagioli P, Alunni G, Murrone A, Zuchi C, Biscottini E, et al. Improvement of myocardial performance (tei) index closely reflects intrinsic improvement of cardiac function: Assessment in revascularized hibernating myocardium. Echocardiography. 2012; 29:298-306. doi: 10.1111/j.1540-8175. 2011.01575.x PMID: 22118328
35. Poelaert JI, Schupfer G. Hemodynamic monitoring utilizing transesophageal echocardiography: The relationships among pressure, flow, and function. Chest. 2005; 127:379-390 PMID: 15654003
36. Severi L, Lappa A, Landoni G, Pirro LD, Luzzi SJ, Caravetta P, et al. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients. J Cardiothorac Vasc Anesth. 2011; 25:632-636 doi: 10.1053/j.jvca.2011.03.001 PMID: 21546269
37. Eris C, Yavuz S, Toktas F, Turk T, Gucu A, Erdolu B, et al. Preoperative usages of levosimendan in patients undergoing coronary artery bypass grafting. Int J Clin Exp Med. 2014; 7:219-229. PMID: 24482709
38. Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: A meta-analysis of randomised cpntrolled trials Critical Care. 2011; 15:140-150.
39. Lobato EB, Willert JL, Looke TD, Thomas J, Urdaneta F. Effects of milrinone versus epinephrine on left ventricular relaxation after cardiopulmonary bypass following myocardial revascularization: Assessment by color m-mode and tissue doppler. J Cardiothorac Vasc Anesth. 2005; 19:334-339. PMID: 16130060
40. Kodali RK, Sundar AS, Vakamudi M, Ravulapali H, Nandipati S, Chandrasekaran N, et al. Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: A randomized controlled study. Annals of Cardiac Anaesthesia. 2013; 162:94-99. PMID: 23545863
41. Blanchard DG, Malouf PJ, Gurudevan SV, Auger WR, Madani MM, Thistlethwaite P, et al. Utility of right ventricular tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. Card Vasc Imag. 2009; 2:143-149
42. Matyal R, Skubas NJ, Shernan SK, Mahmood F. Perioperative assessment of diastolic dysfunction. Anesth Analg. 2011; 113:449-472. PMID: 21813627
43. Lee E-H, Yun S-C, Chin J-H, Choi D-K, Son H-J, Kim W-C, et al. Prognostic implications of preoperative e/e ratio in patients with off-pump coronary artery surgery. Anesthesiology 2012; 116:326-371. PMID: 22222471
44. Antila S, Sundberg S, Lehtonen A. Clinical pharmacology of levosimendan. Clin Pharmacokinet. 2007; 46:535-552. PMID: 17596101
45. Bocchi EA, Vilas-Boas F, Moreira M, Carlos A, Barretto P, Lage S, et al. Levosimendan in decompensated heart failure patients: Efficacy in a brazilian cohort. Results of the belief study. Arq Bras Cardiol. 2008; 90:182-190. PMID: 18392398
46. Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: A meta-analysis of randomised cpntrolled trials. Critical Care. 2011; 15:140-150.
47. Maharaj R. Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia. J Saudi Heart Assoc. 2012; 24:99-121. doi: 10.1016/j.jsha.2012.01.004 PMID: 23960679
48. D'Ascenzo F, Barbero U, Moretti C, Palmerini T, Riva DD, Mariani A, et al. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: MeTa-regression of randomized trials. Contemp Clin Trials. 2014; 38:51-58. PMID: 24657881 doi: 10.1016/j.cct.2014.03.002